Dr. Amanda Guidon is chief of the neuromuscular division and directs the electromyography (EMG) lab at the Massachusetts General Hospital. She is an Assistant Professor of Neurology at Harvard Medical School. Dr. Guidon’s clinical practice is dedicated to patients with neuromuscular disorders, and in particular myasthenia gravis and the neuromuscular immune related adverse events of immunotherapy for cancer. As part of this work, she directs the Myasthenia Gravis Program at MGH and has held leadership positions regionally and nationally in MG, including serving as current chair of the medical and scientific advisory board of the Myasthenia Gravis Foundation of America (MGFA) in New England. Her care was recognized by the MGFA's national physician of the year award in 2020.  Dr. Guidon’s research is focused on improving healthcare delivery and outcomes via novel outcome measures, remote monitoring tools and telemedicine. Her work has been funded by the MGFA, NINDS and the RCDRN’s MGNET Rare Disease Network.  She designs and conducts clinical trials in MG. Dr. Guidon is dedicated to trainee education and has been program director of the Mass General Brigham Neuromuscular Medicine Fellowship since 2018.  

Dr. Guidon received her medical degree from the University of Rochester and completed her Internship in Medicine (2008), and Residency in Neurology (2011) as well as Fellowship in Neuromuscular Medicine (2011-2013) at Duke University Medical Center.  She completed a Masters of Public Health at the TH Chan School of Public Health at Harvard in 2021. Dr. Guidon is board certified in Neurology, Neuromuscular Medicine and Electrodiagnostic Medicine.